Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery

Kjirsten A. Carlson, Cristina Checka, Kelly K. Hunt, Jennifer Jung, Christian Bridges, Puneet Singh, Ana Refinetti, Tanya Moseley, Frances Perez, Cody Mayo, Nina Tamirisa
{"title":"Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery","authors":"Kjirsten A. Carlson, Cristina Checka, Kelly K. Hunt, Jennifer Jung, Christian Bridges, Puneet Singh, Ana Refinetti, Tanya Moseley, Frances Perez, Cody Mayo, Nina Tamirisa","doi":"10.1155/2023/9993852","DOIUrl":null,"url":null,"abstract":"<i>Introduction</i>. Elucent Medical has introduced a novel EnVisio™ Surgical Navigation system which uses SmartClips™ that generate a unique electromagnetic signal triangulated in 3 dimensions for real-time navigation. The purpose of this study was to evaluate the efficacy and feasibility of the EnVisio Surgical Navigation system in localizing and excising nonpalpable lesions in breast and axillary surgery. <i>Methods</i>. This pilot study prospectively examined patients undergoing breast and nodal localization using the EnVisio Surgical Navigation system. SmartClips were placed by designated radiologists using ultrasound (US) or mammographic (MMG) guidance. The technical evaluation focused on successful deployment and subsequent excision of all localized lesions including SmartClips and biopsy clips. <i>Results</i>. Eleven patients underwent localization using 27 SmartClips which included bracketed multifocal disease (<i>n</i> = 4) and clipped lymph node (<i>n</i> = 1). The bracketed cases were each localized with 2 SmartClips. Mammography and ultrasound were used (<i>n</i> = 8 and <i>n</i> = 19, respectively) to place the SmartClips. All 27 devices were successfully deployed within 5 mm of the targeted lesion or biopsy clip. All SmartClip devices were identified and retrieved intraoperatively. No patients required a second operation for margin excision. <i>Conclusion</i>. In a limited sample, the EnVisio Surgical Navigation system was a reliable technology for the localization of breast and axillary lesions planned for surgical excision. Further comparative studies are required to evaluate its efficacy in relation to the other existing localization modalities.","PeriodicalId":501151,"journal":{"name":"The Breast Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Breast Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/9993852","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Elucent Medical has introduced a novel EnVisio™ Surgical Navigation system which uses SmartClips™ that generate a unique electromagnetic signal triangulated in 3 dimensions for real-time navigation. The purpose of this study was to evaluate the efficacy and feasibility of the EnVisio Surgical Navigation system in localizing and excising nonpalpable lesions in breast and axillary surgery. Methods. This pilot study prospectively examined patients undergoing breast and nodal localization using the EnVisio Surgical Navigation system. SmartClips were placed by designated radiologists using ultrasound (US) or mammographic (MMG) guidance. The technical evaluation focused on successful deployment and subsequent excision of all localized lesions including SmartClips and biopsy clips. Results. Eleven patients underwent localization using 27 SmartClips which included bracketed multifocal disease (n = 4) and clipped lymph node (n = 1). The bracketed cases were each localized with 2 SmartClips. Mammography and ultrasound were used (n = 8 and n = 19, respectively) to place the SmartClips. All 27 devices were successfully deployed within 5 mm of the targeted lesion or biopsy clip. All SmartClip devices were identified and retrieved intraoperatively. No patients required a second operation for margin excision. Conclusion. In a limited sample, the EnVisio Surgical Navigation system was a reliable technology for the localization of breast and axillary lesions planned for surgical excision. Further comparative studies are required to evaluate its efficacy in relation to the other existing localization modalities.
评估手术导航系统在乳房和腋窝手术中对无法触及的病灶进行定位和切除的效果
简介。Elucent Medical 公司推出了新颖的 EnVisio™ 手术导航系统,该系统使用 SmartClips™,可产生独特的电磁信号,在三维空间进行三角测量,从而实现实时导航。本研究旨在评估 EnVisio 手术导航系统在乳腺和腋窝手术中定位和切除非肉眼可见病灶的有效性和可行性。方法。这项试验性研究对使用EnVisio手术导航系统进行乳腺和结节定位的患者进行了前瞻性检查。智能夹由指定的放射科医生使用超声(US)或乳腺X线摄影(MMG)引导放置。技术评估的重点是所有定位病灶(包括 SmartClips 和活检夹)的成功部署和后续切除。结果。11 名患者使用 27 个 SmartClips 进行了定位,其中包括括号内的多灶性疾病(4 例)和剪切的淋巴结(1 例)。括号内的病例各使用 2 个 SmartClips 进行定位。使用乳房 X 线照相术和超声检查(分别为 8 例和 19 例)来放置 SmartClips。所有 27 个装置都成功部署在目标病灶或活检夹 5 毫米范围内。所有 SmartClip 装置都在术中被识别并取回。没有患者需要二次手术进行边缘切除。结论。在有限的样本中,EnVisio手术导航系统是对计划进行手术切除的乳腺和腋窝病灶进行定位的可靠技术。需要进一步进行比较研究,以评估其与其他现有定位方式的功效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信